Skip to main content
. Author manuscript; available in PMC: 2014 Sep 22.
Published in final edited form as: Diabetologia. 2012 May;55(5):1283–1290. doi: 10.1007/s00125-012-2471-y

Figure 3. Baseline resting heart rate and the risk of death from any cause stratified by treatment with β-blockers and by atrial fibrillation.

Figure 3

Hazard adjusted for age, sex, ADVANCE study blood pressure treatment arm, ADVANCE study glycaemic control arm, body mass index, duration of diabetes, HbA1c, urinary albumin creatinine ratio, estimated glomerular filtration rate, systolic blood pressure, diastolic blood pressure, history of hospitalisation for heart failure, participation in moderate and/or vigorous exercise for >15 minutes at least once weekly, total cholesterol, triacylglycerol level, atrial fibrillation (only in analysis stratified by treatment with β-blockers), treatment with calcium channel blockers and treatment with β-blockers (only in analysis stratified by history of atrial fibrillation).